

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | gonadal mesoderm development (GO:0007506) | 6.30091150 |
| 2 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 5.58665951 |
| 3 | arginine catabolic process (GO:0006527) | 5.48256855 |
| 4 | protein K6-linked ubiquitination (GO:0085020) | 5.02727741 |
| 5 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 4.97289469 |
| 6 | exogenous drug catabolic process (GO:0042738) | 4.93108159 |
| 7 | response to lipoprotein particle (GO:0055094) | 4.76593329 |
| 8 | piRNA metabolic process (GO:0034587) | 4.74314304 |
| 9 | trophoblast giant cell differentiation (GO:0060707) | 4.68765103 |
| 10 | arginine metabolic process (GO:0006525) | 4.68586340 |
| 11 | diaphragm development (GO:0060539) | 4.67198807 |
| 12 | regulation of RIG-I signaling pathway (GO:0039535) | 4.66324800 |
| 13 | response to UV-B (GO:0010224) | 4.63556874 |
| 14 | negative regulation of neurotransmitter transport (GO:0051589) | 4.55534491 |
| 15 | positive regulation of cell size (GO:0045793) | 4.52458109 |
| 16 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 4.39458860 |
| 17 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.28652894 |
| 18 | regulation of guanylate cyclase activity (GO:0031282) | 4.28192494 |
| 19 | cartilage morphogenesis (GO:0060536) | 4.23518390 |
| 20 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.18864971 |
| 21 | regulation of neurotransmitter uptake (GO:0051580) | 4.13843606 |
| 22 | drug catabolic process (GO:0042737) | 4.10518799 |
| 23 | glycerophospholipid catabolic process (GO:0046475) | 4.10496174 |
| 24 | cellular ketone body metabolic process (GO:0046950) | 4.07043419 |
| 25 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 4.01310287 |
| 26 | nitric oxide mediated signal transduction (GO:0007263) | 3.94507675 |
| 27 | cell differentiation involved in embryonic placenta development (GO:0060706) | 3.93678162 |
| 28 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.91407701 |
| 29 | skeletal muscle organ development (GO:0060538) | 3.81183255 |
| 30 | peptidyl-threonine dephosphorylation (GO:0035970) | 3.75831783 |
| 31 | nuclear pore complex assembly (GO:0051292) | 3.75757905 |
| 32 | N-glycan processing (GO:0006491) | 3.74201310 |
| 33 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.71453842 |
| 34 | regulation of gene silencing by miRNA (GO:0060964) | 3.71453842 |
| 35 | regulation of gene silencing by RNA (GO:0060966) | 3.71453842 |
| 36 | cardiac ventricle formation (GO:0003211) | 3.70515986 |
| 37 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.65258557 |
| 38 | regulation of activation of Janus kinase activity (GO:0010533) | 3.62585928 |
| 39 | RNA-dependent DNA replication (GO:0006278) | 3.56757981 |
| 40 | macrophage chemotaxis (GO:0048246) | 3.53767634 |
| 41 | telomere maintenance via telomerase (GO:0007004) | 3.53450173 |
| 42 | N-acetylneuraminate metabolic process (GO:0006054) | 3.52519631 |
| 43 | nuclear pore organization (GO:0006999) | 3.52457676 |
| 44 | negative regulation of protein oligomerization (GO:0032460) | 3.48176875 |
| 45 | cardiac chamber formation (GO:0003207) | 3.48001771 |
| 46 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 3.46421915 |
| 47 | UMP metabolic process (GO:0046049) | 3.46421915 |
| 48 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 3.46421915 |
| 49 | UMP biosynthetic process (GO:0006222) | 3.46421915 |
| 50 | ketone body metabolic process (GO:1902224) | 3.46393885 |
| 51 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 3.46028055 |
| 52 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 3.46028055 |
| 53 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.46017064 |
| 54 | negative regulation of telomere maintenance (GO:0032205) | 3.44176430 |
| 55 | thrombin receptor signaling pathway (GO:0070493) | 3.39932867 |
| 56 | trophectodermal cell differentiation (GO:0001829) | 3.39085130 |
| 57 | positive regulation of interferon-alpha production (GO:0032727) | 3.36590452 |
| 58 | replicative senescence (GO:0090399) | 3.33773910 |
| 59 | intra-S DNA damage checkpoint (GO:0031573) | 3.30692654 |
| 60 | dendritic cell chemotaxis (GO:0002407) | 3.30377480 |
| 61 | cellular protein complex localization (GO:0034629) | 3.29452226 |
| 62 | DNA methylation involved in gamete generation (GO:0043046) | 3.28738515 |
| 63 | thyroid hormone metabolic process (GO:0042403) | 3.27287738 |
| 64 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.25253318 |
| 65 | regulation of mitochondrial translation (GO:0070129) | 3.24422271 |
| 66 | IMP biosynthetic process (GO:0006188) | 3.23686770 |
| 67 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.22920157 |
| 68 | negative regulation of protein kinase B signaling (GO:0051898) | 3.21925416 |
| 69 | positive regulation of glycolytic process (GO:0045821) | 3.21913105 |
| 70 | type B pancreatic cell development (GO:0003323) | 3.21434549 |
| 71 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.21357950 |
| 72 | nitric oxide biosynthetic process (GO:0006809) | 3.19463634 |
| 73 | signal peptide processing (GO:0006465) | 3.18731089 |
| 74 | receptor recycling (GO:0001881) | 3.18183975 |
| 75 | positive regulation of protein homodimerization activity (GO:0090073) | 3.17830653 |
| 76 | negative regulation of potassium ion transport (GO:0043267) | 3.16304530 |
| 77 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 3.12008348 |
| 78 | DNA strand renaturation (GO:0000733) | 3.11485809 |
| 79 | protein K11-linked deubiquitination (GO:0035871) | 3.11332752 |
| 80 | regulation of interferon-alpha production (GO:0032647) | 3.10271331 |
| 81 | startle response (GO:0001964) | 3.10075976 |
| 82 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.09502921 |
| 83 | facial nerve structural organization (GO:0021612) | 3.08712365 |
| 84 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.08673741 |
| 85 | pore complex assembly (GO:0046931) | 3.07932721 |
| 86 | glucosamine-containing compound catabolic process (GO:1901072) | 3.07698516 |
| 87 | dendritic cell migration (GO:0036336) | 3.03074445 |
| 88 | response to parathyroid hormone (GO:0071107) | 3.01154921 |
| 89 | mammary gland epithelial cell proliferation (GO:0033598) | 3.01136541 |
| 90 | synapsis (GO:0007129) | 3.00970465 |
| 91 | keratinocyte development (GO:0003334) | 3.00234554 |
| 92 | thyroid hormone generation (GO:0006590) | 2.98448632 |
| 93 | L-fucose catabolic process (GO:0042355) | 2.98204776 |
| 94 | fucose catabolic process (GO:0019317) | 2.98204776 |
| 95 | L-fucose metabolic process (GO:0042354) | 2.98204776 |
| 96 | DNA replication checkpoint (GO:0000076) | 2.96272261 |
| 97 | pyrimidine nucleoside salvage (GO:0043097) | 2.95380105 |
| 98 | pyrimidine-containing compound salvage (GO:0008655) | 2.95380105 |
| 99 | regulation of interleukin-1 secretion (GO:0050704) | 2.94520909 |
| 100 | macroautophagy (GO:0016236) | 2.92964401 |
| 101 | regulation of hippo signaling (GO:0035330) | 2.91536925 |
| 102 | hepatocyte apoptotic process (GO:0097284) | 2.89004154 |
| 103 | neurotransmitter biosynthetic process (GO:0042136) | 2.87441933 |
| 104 | regulation of helicase activity (GO:0051095) | 2.86336534 |
| 105 | histone H3-K4 methylation (GO:0051568) | 2.85874743 |
| 106 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.84185851 |
| 107 | superoxide anion generation (GO:0042554) | 2.83191476 |
| 108 | DNA replication initiation (GO:0006270) | 2.83127905 |
| 109 | regulation of protein glycosylation (GO:0060049) | 2.81034270 |
| 110 | negative regulation of DNA repair (GO:0045738) | 2.79795679 |
| 111 | lymphocyte chemotaxis (GO:0048247) | 2.79154002 |
| 112 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.78999870 |
| 113 | negative regulation of gluconeogenesis (GO:0045721) | 2.77990977 |
| 114 | endocrine pancreas development (GO:0031018) | 2.77277748 |
| 115 | meiotic chromosome segregation (GO:0045132) | 2.76885945 |
| 116 | telomere maintenance via telomere lengthening (GO:0010833) | 2.75395389 |
| 117 | protein localization to microtubule (GO:0035372) | 2.75108679 |
| 118 | TOR signaling (GO:0031929) | 2.72919562 |
| 119 | righting reflex (GO:0060013) | 2.72451109 |
| 120 | keratan sulfate catabolic process (GO:0042340) | 2.71460759 |
| 121 | positive regulation of mRNA catabolic process (GO:0061014) | 2.70797677 |
| 122 | proline transport (GO:0015824) | 2.69286272 |
| 123 | nucleobase biosynthetic process (GO:0046112) | 2.67118505 |
| 124 | RNA destabilization (GO:0050779) | 2.66577131 |
| 125 | negative regulation of mast cell activation (GO:0033004) | 2.65692845 |
| 126 | bile acid and bile salt transport (GO:0015721) | 2.65340950 |
| 127 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.61029455 |
| 128 | regulation of mRNA catabolic process (GO:0061013) | 2.60956592 |
| 129 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.60311733 |
| 130 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.59991017 |
| 131 | negative regulation of viral genome replication (GO:0045071) | 2.59937254 |
| 132 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.59728343 |
| 133 | purine nucleobase biosynthetic process (GO:0009113) | 2.58520506 |
| 134 | DNA deamination (GO:0045006) | 2.58515296 |
| 135 | proteasome assembly (GO:0043248) | 2.57987887 |
| 136 | regulation of interleukin-8 secretion (GO:2000482) | 2.57313191 |
| 137 | phosphate ion homeostasis (GO:0055062) | 2.55090861 |
| 138 | trivalent inorganic anion homeostasis (GO:0072506) | 2.55090861 |
| 139 | glandular epithelial cell development (GO:0002068) | 2.53055564 |
| 140 | embryonic heart tube development (GO:0035050) | 2.52573120 |
| 141 | nucleotide transmembrane transport (GO:1901679) | 2.52437707 |
| 142 | pantothenate metabolic process (GO:0015939) | 2.52041402 |
| 143 | positive regulation of interleukin-1 production (GO:0032732) | 2.50922897 |
| 144 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.50518510 |
| 145 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 2.49649170 |
| 146 | negative regulation of acute inflammatory response (GO:0002674) | 2.49131890 |
| 147 | regulation of keratinocyte proliferation (GO:0010837) | 2.48769157 |
| 148 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.48698273 |
| 149 | positive regulation of cyclase activity (GO:0031281) | 2.48574201 |
| 150 | regulation of synapse maturation (GO:0090128) | 2.48093380 |
| 151 | positive regulation of interleukin-12 production (GO:0032735) | 2.46897485 |
| 152 | rRNA catabolic process (GO:0016075) | 2.46354724 |
| 153 | positive regulation of response to biotic stimulus (GO:0002833) | 2.45475477 |
| 154 | long-term synaptic potentiation (GO:0060291) | 2.45096692 |
| 155 | respiratory chain complex IV assembly (GO:0008535) | 2.44688308 |
| 156 | regulation of gene silencing (GO:0060968) | 2.44344039 |
| 157 | negative regulation of glycogen metabolic process (GO:0070874) | 2.43144453 |
| 158 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.42182158 |
| 159 | postsynaptic membrane organization (GO:0001941) | 2.41978351 |
| 160 | monocyte chemotaxis (GO:0002548) | 2.41602721 |
| 161 | gene silencing by RNA (GO:0031047) | 2.41469190 |
| 162 | post-embryonic morphogenesis (GO:0009886) | 2.41322948 |
| 163 | phasic smooth muscle contraction (GO:0014821) | 2.41297307 |
| 164 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 2.40761500 |
| 165 | neutrophil activation (GO:0042119) | 2.40116716 |
| 166 | plasma membrane fusion (GO:0045026) | 2.39588328 |
| 167 | inositol phosphate-mediated signaling (GO:0048016) | 2.39146290 |
| 168 | positive regulation of lyase activity (GO:0051349) | 2.38821952 |
| 169 | positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517) | 2.38158990 |
| 170 | nucleoside transmembrane transport (GO:1901642) | 2.37362815 |
| 171 | positive regulation of viral genome replication (GO:0045070) | 2.37303546 |
| 172 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.37134923 |
| 173 | detection of light stimulus involved in visual perception (GO:0050908) | 2.37134923 |
| 174 | pinocytosis (GO:0006907) | 2.36874404 |
| 175 | DNA synthesis involved in DNA repair (GO:0000731) | 2.36590254 |
| 176 | cellular response to toxic substance (GO:0097237) | 2.36166064 |
| 177 | regulation of germinal center formation (GO:0002634) | 2.35052354 |
| 178 | positive regulation of vasodilation (GO:0045909) | 2.34800193 |
| 179 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.34798025 |
| 180 | regulation of cGMP biosynthetic process (GO:0030826) | 2.34634998 |
| 181 | nucleoside salvage (GO:0043174) | 2.34613486 |
| 182 | sphingomyelin metabolic process (GO:0006684) | 2.34529948 |
| 183 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.34239924 |
| 184 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.32845734 |
| 185 | cellular response to glucose starvation (GO:0042149) | 2.32648084 |
| 186 | histone H2A monoubiquitination (GO:0035518) | 2.32346423 |
| 187 | regulation of DNA-dependent DNA replication (GO:0090329) | 2.32196680 |
| 188 | positive regulation of immune response to tumor cell (GO:0002839) | 2.29990203 |
| 189 | regulation of immune response to tumor cell (GO:0002837) | 2.29990203 |
| 190 | regulation of response to tumor cell (GO:0002834) | 2.29990203 |
| 191 | positive regulation of response to tumor cell (GO:0002836) | 2.29990203 |
| 192 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.29378171 |
| 193 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.28959988 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 9.67490418 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.81838759 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.79420777 |
| 4 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 3.38002174 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.36398122 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.26859567 |
| 7 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.18742589 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.11419711 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.05380622 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.92447519 |
| 11 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.61006498 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.42592003 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.38953343 |
| 14 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.37532715 |
| 15 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 2.29305833 |
| 16 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.22820771 |
| 17 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.21650725 |
| 18 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.18034221 |
| 19 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.13081887 |
| 20 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.04857910 |
| 21 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.01132043 |
| 22 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.00554134 |
| 23 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 2.00004877 |
| 24 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.97703481 |
| 25 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.97166860 |
| 26 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.91414015 |
| 27 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.85734221 |
| 28 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.84590622 |
| 29 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.79714571 |
| 30 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.76804848 |
| 31 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.74625003 |
| 32 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.74061492 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.73687728 |
| 34 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.70783195 |
| 35 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.67688019 |
| 36 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.67161588 |
| 37 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.65276295 |
| 38 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.64909983 |
| 39 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.61247749 |
| 40 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.59674909 |
| 41 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.59271625 |
| 42 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.58792020 |
| 43 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.54918370 |
| 44 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.53830819 |
| 45 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.53519601 |
| 46 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.51554375 |
| 47 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.51255261 |
| 48 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.51255261 |
| 49 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.50883383 |
| 50 | * RBPJ_21746931_ChIP-Seq_IB4_Human | 1.49136788 |
| 51 | * ETV1_20927104_ChIP-Seq_GIST48_Human | 1.48820044 |
| 52 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.45938027 |
| 53 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.44948379 |
| 54 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.44768057 |
| 55 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.42397275 |
| 56 | * CBX2_22325352_ChIP-Seq_293T-Rex_Human | 1.41450725 |
| 57 | EWS_26573619_Chip-Seq_HEK293_Human | 1.39796084 |
| 58 | ERA_21632823_ChIP-Seq_H3396_Human | 1.38483647 |
| 59 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.37786443 |
| 60 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.37744050 |
| 61 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.37382900 |
| 62 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.36488180 |
| 63 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.36432352 |
| 64 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.35958544 |
| 65 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.35297309 |
| 66 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.35156961 |
| 67 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.34399771 |
| 68 | GATA3_26560356_Chip-Seq_TH2_Human | 1.33943488 |
| 69 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.33615017 |
| 70 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.33589287 |
| 71 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.33471459 |
| 72 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.33339510 |
| 73 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.33339510 |
| 74 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.32775284 |
| 75 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.31622180 |
| 76 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.29268051 |
| 77 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.28895976 |
| 78 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.27855713 |
| 79 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.26964543 |
| 80 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.26924321 |
| 81 | STAT3_23295773_ChIP-Seq_U87_Human | 1.26899717 |
| 82 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.25929222 |
| 83 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.24323932 |
| 84 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.22414217 |
| 85 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.21004570 |
| 86 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.20834393 |
| 87 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.19950135 |
| 88 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.19002569 |
| 89 | FUS_26573619_Chip-Seq_HEK293_Human | 1.18919367 |
| 90 | * PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.18691999 |
| 91 | * PHF8_20622853_ChIP-Seq_HELA_Human | 1.18534524 |
| 92 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.17754713 |
| 93 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.17404692 |
| 94 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.17083821 |
| 95 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.16499688 |
| 96 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.16499688 |
| 97 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.16499688 |
| 98 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.15855448 |
| 99 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.14887869 |
| 100 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.14276836 |
| 101 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.13796638 |
| 102 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.13199427 |
| 103 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.12597847 |
| 104 | VDR_22108803_ChIP-Seq_LS180_Human | 1.12539097 |
| 105 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.11523642 |
| 106 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.11436765 |
| 107 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10832343 |
| 108 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.10288670 |
| 109 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.10038340 |
| 110 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.09797973 |
| 111 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.09778444 |
| 112 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.09590242 |
| 113 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.09441289 |
| 114 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.08451289 |
| 115 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.08260902 |
| 116 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.07852525 |
| 117 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.07787265 |
| 118 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.07705252 |
| 119 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.07535546 |
| 120 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.07210999 |
| 121 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.06862049 |
| 122 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.06542562 |
| 123 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.06191116 |
| 124 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.05941507 |
| 125 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.05417714 |
| 126 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.05388224 |
| 127 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04891873 |
| 128 | * NFYA_21822215_ChIP-Seq_K562_Human | 1.04884658 |
| 129 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.04075613 |
| 130 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.03724961 |
| 131 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02949653 |
| 132 | * TBL1_22424771_ChIP-Seq_293T_Human | 1.02712868 |
| 133 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.02602976 |
| 134 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.02432255 |
| 135 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.02363333 |
| 136 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01775709 |
| 137 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.01442541 |
| 138 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.00866424 |
| 139 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.00833739 |
| 140 | * NFYB_21822215_ChIP-Seq_K562_Human | 0.99918860 |
| 141 | MYB_26560356_Chip-Seq_TH1_Human | 0.99894945 |
| 142 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.99500050 |
| 143 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.99494929 |
| 144 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.99228472 |
| 145 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.98655571 |
| 146 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.98399632 |
| 147 | MYB_26560356_Chip-Seq_TH2_Human | 0.98252554 |
| 148 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.97792055 |
| 149 | NCOR_22424771_ChIP-Seq_293T_Human | 0.97192259 |
| 150 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.97179351 |
| 151 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.97168535 |
| 152 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.96381197 |
| 153 | AR_20517297_ChIP-Seq_VCAP_Human | 0.95905021 |
| 154 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.95767907 |
| 155 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.95755218 |
| 156 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.95703030 |
| 157 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95601304 |
| 158 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95579945 |
| 159 | P300_27268052_Chip-Seq_Bcells_Human | 0.95575991 |
| 160 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.95206810 |
| 161 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95199670 |
| 162 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.95176594 |
| 163 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.93727610 |
| 164 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.93727610 |
| 165 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.93669175 |
| 166 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.93334682 |
| 167 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.93333819 |
| 168 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.93086381 |
| 169 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.93086381 |
| 170 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92373105 |
| 171 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92322328 |
| 172 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92266088 |
| 173 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.91690477 |
| 174 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.91604755 |
| 175 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.91585903 |
| 176 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.91264950 |
| 177 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.91158785 |
| 178 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.90781044 |
| 179 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.90624693 |
| 180 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90069772 |
| 181 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.89902902 |
| 182 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.89885630 |
| 183 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.89665470 |
| 184 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.89451125 |
| 185 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.88794100 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 5.40402485 |
| 2 | MP0004264_abnormal_extraembryonic_tissu | 4.94707276 |
| 3 | MP0003646_muscle_fatigue | 4.01020010 |
| 4 | MP0004043_abnormal_pH_regulation | 3.90969066 |
| 5 | MP0003195_calcinosis | 3.87354322 |
| 6 | MP0005645_abnormal_hypothalamus_physiol | 3.14693205 |
| 7 | MP0003283_abnormal_digestive_organ | 3.09068359 |
| 8 | MP0000566_synostosis | 2.96477172 |
| 9 | MP0008058_abnormal_DNA_repair | 2.88089660 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.84655558 |
| 11 | MP0003111_abnormal_nucleus_morphology | 2.79399399 |
| 12 | MP0005167_abnormal_blood-brain_barrier | 2.58129992 |
| 13 | MP0002009_preneoplasia | 2.57351868 |
| 14 | MP0010094_abnormal_chromosome_stability | 2.57106625 |
| 15 | MP0000490_abnormal_crypts_of | 2.54546281 |
| 16 | MP0002396_abnormal_hematopoietic_system | 2.47090581 |
| 17 | MP0009785_altered_susceptibility_to | 2.44590102 |
| 18 | MP0003045_fibrosis | 2.37032177 |
| 19 | MP0002876_abnormal_thyroid_physiology | 2.28692120 |
| 20 | MP0005174_abnormal_tail_pigmentation | 2.26587923 |
| 21 | MP0004084_abnormal_cardiac_muscle | 2.25468996 |
| 22 | MP0004858_abnormal_nervous_system | 2.13521620 |
| 23 | MP0000470_abnormal_stomach_morphology | 2.02503722 |
| 24 | MP0003941_abnormal_skin_development | 2.02190949 |
| 25 | MP0005310_abnormal_salivary_gland | 1.95930123 |
| 26 | MP0003890_abnormal_embryonic-extraembry | 1.95552012 |
| 27 | MP0000015_abnormal_ear_pigmentation | 1.91927433 |
| 28 | MP0008057_abnormal_DNA_replication | 1.87548606 |
| 29 | MP0005671_abnormal_response_to | 1.85082255 |
| 30 | MP0002148_abnormal_hypersensitivity_rea | 1.84590281 |
| 31 | MP0010352_gastrointestinal_tract_polyps | 1.84298204 |
| 32 | MP0003937_abnormal_limbs/digits/tail_de | 1.82251082 |
| 33 | MP0000569_abnormal_digit_pigmentation | 1.79649263 |
| 34 | MP0003077_abnormal_cell_cycle | 1.78599849 |
| 35 | MP0005646_abnormal_pituitary_gland | 1.75535712 |
| 36 | MP0008007_abnormal_cellular_replicative | 1.75293235 |
| 37 | MP0003787_abnormal_imprinting | 1.70390091 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.66899151 |
| 39 | MP0001501_abnormal_sleep_pattern | 1.65271779 |
| 40 | MP0005220_abnormal_exocrine_pancreas | 1.64061461 |
| 41 | MP0005360_urolithiasis | 1.63093810 |
| 42 | MP0008775_abnormal_heart_ventricle | 1.61875512 |
| 43 | MP0001765_abnormal_ion_homeostasis | 1.61482983 |
| 44 | MP0001944_abnormal_pancreas_morphology | 1.58738492 |
| 45 | MP0002822_catalepsy | 1.54017851 |
| 46 | MP0003567_abnormal_fetal_cardiomyocyte | 1.53927291 |
| 47 | MP0003121_genomic_imprinting | 1.50788139 |
| 48 | MP0001764_abnormal_homeostasis | 1.50704007 |
| 49 | MP0004233_abnormal_muscle_weight | 1.49138692 |
| 50 | MP0008004_abnormal_stomach_pH | 1.47157659 |
| 51 | MP0002168_other_aberrant_phenotype | 1.44449111 |
| 52 | MP0004484_altered_response_of | 1.41892198 |
| 53 | MP0005332_abnormal_amino_acid | 1.41459371 |
| 54 | MP0003693_abnormal_embryo_hatching | 1.38959425 |
| 55 | MP0001188_hyperpigmentation | 1.36600304 |
| 56 | MP0010329_abnormal_lipoprotein_level | 1.36307648 |
| 57 | MP0005248_abnormal_Harderian_gland | 1.36252582 |
| 58 | MP0002909_abnormal_adrenal_gland | 1.35771093 |
| 59 | MP0002653_abnormal_ependyma_morphology | 1.35731590 |
| 60 | MP0004510_myositis | 1.34511911 |
| 61 | MP0003566_abnormal_cell_adhesion | 1.32522059 |
| 62 | MP0001661_extended_life_span | 1.32510736 |
| 63 | MP0001348_abnormal_lacrimal_gland | 1.32481953 |
| 64 | MP0002693_abnormal_pancreas_physiology | 1.30099807 |
| 65 | MP0002166_altered_tumor_susceptibility | 1.29083525 |
| 66 | MP0006292_abnormal_olfactory_placode | 1.28148365 |
| 67 | MP0005395_other_phenotype | 1.25948577 |
| 68 | MP0003786_premature_aging | 1.25437078 |
| 69 | MP0001346_abnormal_lacrimal_gland | 1.24595580 |
| 70 | MP0005365_abnormal_bile_salt | 1.23893712 |
| 71 | MP0003828_pulmonary_edema | 1.22548039 |
| 72 | MP0010307_abnormal_tumor_latency | 1.21949415 |
| 73 | MP0003718_maternal_effect | 1.21036741 |
| 74 | MP0003866_abnormal_defecation | 1.19066192 |
| 75 | MP0004019_abnormal_vitamin_homeostasis | 1.18700794 |
| 76 | MP0004133_heterotaxia | 1.18120318 |
| 77 | MP0010678_abnormal_skin_adnexa | 1.17129457 |
| 78 | MP0001756_abnormal_urination | 1.16692789 |
| 79 | MP0002837_dystrophic_cardiac_calcinosis | 1.16506649 |
| 80 | MP0009643_abnormal_urine_homeostasis | 1.15948673 |
| 81 | MP0003122_maternal_imprinting | 1.15785966 |
| 82 | MP0001873_stomach_inflammation | 1.15764856 |
| 83 | MP0002277_abnormal_respiratory_mucosa | 1.15114189 |
| 84 | MP0008872_abnormal_physiological_respon | 1.14647868 |
| 85 | MP0003123_paternal_imprinting | 1.14537620 |
| 86 | MP0004381_abnormal_hair_follicle | 1.13429672 |
| 87 | MP0005058_abnormal_lysosome_morphology | 1.12724811 |
| 88 | MP0001666_abnormal_nutrient_absorption | 1.11977743 |
| 89 | MP0000428_abnormal_craniofacial_morphol | 1.11756681 |
| 90 | MP0000427_abnormal_hair_cycle | 1.11404339 |
| 91 | MP0003879_abnormal_hair_cell | 1.11093881 |
| 92 | MP0005025_abnormal_response_to | 1.10009463 |
| 93 | MP0005408_hypopigmentation | 1.09931787 |
| 94 | MP0003136_yellow_coat_color | 1.09545265 |
| 95 | MP0000631_abnormal_neuroendocrine_gland | 1.09278033 |
| 96 | MP0005379_endocrine/exocrine_gland_phen | 1.09136017 |
| 97 | MP0002928_abnormal_bile_duct | 1.08823654 |
| 98 | MP0001986_abnormal_taste_sensitivity | 1.08131064 |
| 99 | MP0005000_abnormal_immune_tolerance | 1.04441395 |
| 100 | MP0004957_abnormal_blastocyst_morpholog | 1.03927959 |
| 101 | MP0003942_abnormal_urinary_system | 1.03206748 |
| 102 | MP0003119_abnormal_digestive_system | 1.02036698 |
| 103 | MP0003755_abnormal_palate_morphology | 1.00069101 |
| 104 | MP0005387_immune_system_phenotype | 0.99808900 |
| 105 | MP0001790_abnormal_immune_system | 0.99808900 |
| 106 | MP0000538_abnormal_urinary_bladder | 0.99627378 |
| 107 | MP0002139_abnormal_hepatobiliary_system | 0.99086909 |
| 108 | MP0005075_abnormal_melanosome_morpholog | 0.98862006 |
| 109 | MP0004036_abnormal_muscle_relaxation | 0.97970594 |
| 110 | MP0002127_abnormal_cardiovascular_syste | 0.97681143 |
| 111 | * MP0005076_abnormal_cell_differentiation | 0.97362192 |
| 112 | MP0000579_abnormal_nail_morphology | 0.96100033 |
| 113 | MP0003436_decreased_susceptibility_to | 0.94952829 |
| 114 | MP0003448_altered_tumor_morphology | 0.94787444 |
| 115 | MP0000350_abnormal_cell_proliferation | 0.94699009 |
| 116 | MP0010368_abnormal_lymphatic_system | 0.93741558 |
| 117 | MP0002452_abnormal_antigen_presenting | 0.93699746 |
| 118 | MP0002160_abnormal_reproductive_system | 0.93570296 |
| 119 | MP0005623_abnormal_meninges_morphology | 0.92856144 |
| 120 | MP0005085_abnormal_gallbladder_physiolo | 0.92832813 |
| 121 | MP0001664_abnormal_digestion | 0.92764148 |
| 122 | MP0001819_abnormal_immune_cell | 0.92447570 |
| 123 | MP0009053_abnormal_anal_canal | 0.92158860 |
| 124 | MP0002098_abnormal_vibrissa_morphology | 0.92136304 |
| 125 | MP0000613_abnormal_salivary_gland | 0.91271730 |
| 126 | MP0003763_abnormal_thymus_physiology | 0.90258383 |
| 127 | MP0002078_abnormal_glucose_homeostasis | 0.90232481 |
| 128 | MP0001800_abnormal_humoral_immune | 0.90100009 |
| 129 | MP0005551_abnormal_eye_electrophysiolog | 0.90086510 |
| 130 | MP0000465_gastrointestinal_hemorrhage | 0.88693585 |
| 131 | MP0004197_abnormal_fetal_growth/weight/ | 0.88560010 |
| 132 | MP0002234_abnormal_pharynx_morphology | 0.87664652 |
| 133 | MP0001293_anophthalmia | 0.87545576 |
| 134 | MP0005083_abnormal_biliary_tract | 0.87324347 |
| 135 | MP0003385_abnormal_body_wall | 0.86314175 |
| 136 | MP0005257_abnormal_intraocular_pressure | 0.86277913 |
| 137 | MP0002420_abnormal_adaptive_immunity | 0.86270372 |
| 138 | MP0000467_abnormal_esophagus_morphology | 0.85883432 |
| 139 | MP0002419_abnormal_innate_immunity | 0.85277893 |
| 140 | MP0002118_abnormal_lipid_homeostasis | 0.84987648 |
| 141 | MP0002111_abnormal_tail_morphology | 0.84153036 |
| 142 | MP0003172_abnormal_lysosome_physiology | 0.83948633 |
| 143 | MP0002896_abnormal_bone_mineralization | 0.83861678 |
| 144 | MP0003252_abnormal_bile_duct | 0.83733347 |
| 145 | MP0000383_abnormal_hair_follicle | 0.82429358 |
| 146 | MP0008877_abnormal_DNA_methylation | 0.81891464 |
| 147 | MP0002109_abnormal_limb_morphology | 0.81197006 |
| 148 | MP0000609_abnormal_liver_physiology | 0.80951201 |
| 149 | MP0001119_abnormal_female_reproductive | 0.80519745 |
| 150 | MP0002115_abnormal_skeleton_extremities | 0.80513010 |
| 151 | MP0010155_abnormal_intestine_physiology | 0.79659088 |
| 152 | MP0009046_muscle_twitch | 0.79517123 |
| 153 | MP0001270_distended_abdomen | 0.78874139 |
| 154 | MP0005636_abnormal_mineral_homeostasis | 0.78828872 |
| 155 | MP0002970_abnormal_white_adipose | 0.78273423 |
| 156 | MP0000681_abnormal_thyroid_gland | 0.77736914 |
| 157 | MP0002006_tumorigenesis | 0.77075874 |
| 158 | MP0010030_abnormal_orbit_morphology | 0.76867199 |
| 159 | MP0000432_abnormal_head_morphology | 0.76518439 |
| 160 | MP0001663_abnormal_digestive_system | 0.75780915 |
| 161 | MP0003936_abnormal_reproductive_system | 0.75505537 |
| 162 | MP0000477_abnormal_intestine_morphology | 0.74947511 |
| 163 | MP0003868_abnormal_feces_composition | 0.74393700 |
| 164 | MP0005451_abnormal_body_composition | 0.74190333 |
| 165 | MP0009840_abnormal_foam_cell | 0.73569486 |
| 166 | MP0003953_abnormal_hormone_level | 0.73456680 |
| 167 | MP0001324_abnormal_eye_pigmentation | 0.73341476 |
| 168 | MP0006082_CNS_inflammation | 0.73256316 |
| 169 | MP0008932_abnormal_embryonic_tissue | 0.73208972 |
| 170 | MP0000516_abnormal_urinary_system | 0.72741579 |
| 171 | MP0005367_renal/urinary_system_phenotyp | 0.72741579 |
| 172 | MP0002019_abnormal_tumor_incidence | 0.72683233 |
| 173 | MP0002136_abnormal_kidney_physiology | 0.71977522 |
| 174 | MP0002163_abnormal_gland_morphology | 0.69483427 |
| 175 | MP0004742_abnormal_vestibular_system | 0.69410530 |
| 176 | MP0005171_absent_coat_pigmentation | 0.66820888 |
| 177 | MP0003943_abnormal_hepatobiliary_system | 0.66435142 |
| 178 | MP0004885_abnormal_endolymph | 0.63515358 |
| 179 | MP0005410_abnormal_fertilization | 0.60631150 |
| 180 | MP0001968_abnormal_touch/_nociception | 0.60440250 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased density of long bones (HP:0006392) | 6.30035052 |
| 2 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 6.20010707 |
| 3 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 5.35201099 |
| 4 | Hypophosphatemic rickets (HP:0004912) | 5.12108084 |
| 5 | Papilledema (HP:0001085) | 4.85904305 |
| 6 | Chromsome breakage (HP:0040012) | 4.77594611 |
| 7 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 3.82876132 |
| 8 | Ketoacidosis (HP:0001993) | 3.80208304 |
| 9 | Clubbing of toes (HP:0100760) | 3.78969817 |
| 10 | 11 pairs of ribs (HP:0000878) | 3.74626560 |
| 11 | Abnormality of the anterior horn cell (HP:0006802) | 3.70993988 |
| 12 | Degeneration of anterior horn cells (HP:0002398) | 3.70993988 |
| 13 | Abnormality of the preputium (HP:0100587) | 3.58301602 |
| 14 | Lower limb hyperreflexia (HP:0002395) | 3.56742889 |
| 15 | Curly hair (HP:0002212) | 3.49646134 |
| 16 | Spinal muscular atrophy (HP:0007269) | 3.47399497 |
| 17 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.46644180 |
| 18 | Sparse lateral eyebrow (HP:0005338) | 3.43256959 |
| 19 | Abnormality of DNA repair (HP:0003254) | 3.36446330 |
| 20 | Ectopic kidney (HP:0000086) | 3.33454364 |
| 21 | Intestinal fistula (HP:0100819) | 3.33089097 |
| 22 | Lip pit (HP:0100267) | 3.31028749 |
| 23 | Short nail (HP:0001799) | 3.22502557 |
| 24 | Pili torti (HP:0003777) | 3.11121571 |
| 25 | Hypoglycemic coma (HP:0001325) | 3.09091938 |
| 26 | Meckel diverticulum (HP:0002245) | 3.05786681 |
| 27 | Congenital sensorineural hearing impairment (HP:0008527) | 2.97002199 |
| 28 | High anterior hairline (HP:0009890) | 2.96870503 |
| 29 | Polydipsia (HP:0001959) | 2.96365706 |
| 30 | Abnormal drinking behavior (HP:0030082) | 2.96365706 |
| 31 | Abnormality of chromosome stability (HP:0003220) | 2.92197120 |
| 32 | Vascular calcification (HP:0004934) | 2.91938669 |
| 33 | Colon cancer (HP:0003003) | 2.91611108 |
| 34 | Metaphyseal dysplasia (HP:0100255) | 2.90305001 |
| 35 | Autoimmune thrombocytopenia (HP:0001973) | 2.87100387 |
| 36 | Hyperglycemia (HP:0003074) | 2.84821234 |
| 37 | Neoplasm of the adrenal cortex (HP:0100641) | 2.80339555 |
| 38 | Abnormality of the vertebral endplates (HP:0005106) | 2.78173962 |
| 39 | Abnormality of the ileum (HP:0001549) | 2.77926102 |
| 40 | Mild short stature (HP:0003502) | 2.76006148 |
| 41 | Duplicated collecting system (HP:0000081) | 2.75265899 |
| 42 | Oligodactyly (hands) (HP:0001180) | 2.72817771 |
| 43 | Enlarged epiphyses (HP:0010580) | 2.72759833 |
| 44 | Stomach cancer (HP:0012126) | 2.72368137 |
| 45 | Micronodular cirrhosis (HP:0001413) | 2.67530780 |
| 46 | Ketosis (HP:0001946) | 2.66489442 |
| 47 | Abnormality of the renal cortex (HP:0011035) | 2.65647550 |
| 48 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.65595792 |
| 49 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.65595792 |
| 50 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.65595792 |
| 51 | Depressed nasal tip (HP:0000437) | 2.64993890 |
| 52 | Esophageal atresia (HP:0002032) | 2.64021247 |
| 53 | Posterior subcapsular cataract (HP:0007787) | 2.63133116 |
| 54 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.62203503 |
| 55 | Mucopolysacchariduria (HP:0008155) | 2.62203503 |
| 56 | Fibular aplasia (HP:0002990) | 2.60792139 |
| 57 | Absent radius (HP:0003974) | 2.59086536 |
| 58 | Missing ribs (HP:0000921) | 2.59075892 |
| 59 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.55225166 |
| 60 | Absent thumb (HP:0009777) | 2.53463031 |
| 61 | Decreased circulating renin level (HP:0003351) | 2.52156362 |
| 62 | Tubular atrophy (HP:0000092) | 2.50771359 |
| 63 | Abnormality of the fingertips (HP:0001211) | 2.49118150 |
| 64 | Cardiovascular calcification (HP:0011915) | 2.49027801 |
| 65 | Mesomelia (HP:0003027) | 2.48991073 |
| 66 | Severe visual impairment (HP:0001141) | 2.47926105 |
| 67 | Weak cry (HP:0001612) | 2.46985258 |
| 68 | Dysostosis multiplex (HP:0000943) | 2.46760099 |
| 69 | Absent forearm bone (HP:0003953) | 2.43904824 |
| 70 | Aplasia involving forearm bones (HP:0009822) | 2.43904824 |
| 71 | Retrobulbar optic neuritis (HP:0100654) | 2.42797503 |
| 72 | Optic neuritis (HP:0100653) | 2.42797503 |
| 73 | Popliteal pterygium (HP:0009756) | 2.42706372 |
| 74 | Prostate neoplasm (HP:0100787) | 2.39669835 |
| 75 | Increased cerebral lipofuscin (HP:0011813) | 2.39558797 |
| 76 | Duodenal stenosis (HP:0100867) | 2.37956302 |
| 77 | Small intestinal stenosis (HP:0012848) | 2.37956302 |
| 78 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.37528256 |
| 79 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.37212990 |
| 80 | Encephalitis (HP:0002383) | 2.33867973 |
| 81 | Oligodactyly (HP:0012165) | 2.33698188 |
| 82 | Abnormality of the renal collecting system (HP:0004742) | 2.33152063 |
| 83 | Ureteral stenosis (HP:0000071) | 2.32832519 |
| 84 | Short 5th finger (HP:0009237) | 2.32746623 |
| 85 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.31475889 |
| 86 | Recurrent cutaneous fungal infections (HP:0011370) | 2.31475889 |
| 87 | Stridor (HP:0010307) | 2.29774761 |
| 88 | Diaphragmatic weakness (HP:0009113) | 2.28658904 |
| 89 | Abnormality of urine glucose concentration (HP:0011016) | 2.26923212 |
| 90 | Glycosuria (HP:0003076) | 2.26923212 |
| 91 | Syringomyelia (HP:0003396) | 2.25536421 |
| 92 | Spinal cord lesions (HP:0100561) | 2.25536421 |
| 93 | Abnormality of the carotid arteries (HP:0005344) | 2.24805690 |
| 94 | Type II lissencephaly (HP:0007260) | 2.22013534 |
| 95 | Metaphyseal irregularity (HP:0003025) | 2.21930088 |
| 96 | Osteomalacia (HP:0002749) | 2.19987146 |
| 97 | Rickets (HP:0002748) | 2.17514692 |
| 98 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 2.15588084 |
| 99 | Congenital stationary night blindness (HP:0007642) | 2.15548447 |
| 100 | Volvulus (HP:0002580) | 2.15460425 |
| 101 | Petechiae (HP:0000967) | 2.15298267 |
| 102 | Constricted visual fields (HP:0001133) | 2.15168579 |
| 103 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.15148723 |
| 104 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.15148723 |
| 105 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.14944318 |
| 106 | Optic nerve coloboma (HP:0000588) | 2.13960998 |
| 107 | Ureteral obstruction (HP:0006000) | 2.13478555 |
| 108 | Abnormality of the duodenum (HP:0002246) | 2.12361876 |
| 109 | Submucous cleft hard palate (HP:0000176) | 2.11272765 |
| 110 | Facial diplegia (HP:0001349) | 2.09876504 |
| 111 | Triphalangeal thumb (HP:0001199) | 2.09472864 |
| 112 | Progressive visual loss (HP:0000529) | 2.08634206 |
| 113 | Increased CSF protein (HP:0002922) | 2.07281687 |
| 114 | Type 2 muscle fiber atrophy (HP:0003554) | 2.04545012 |
| 115 | Renal cortical cysts (HP:0000803) | 2.02090413 |
| 116 | Abnormality of renin-angiotensin system (HP:0000847) | 2.01983793 |
| 117 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.01894892 |
| 118 | Hypophosphatemia (HP:0002148) | 2.01572716 |
| 119 | Abnormality of the labia minora (HP:0012880) | 2.01249711 |
| 120 | Bone marrow hypocellularity (HP:0005528) | 2.00172125 |
| 121 | Alveolar cell carcinoma (HP:0006519) | 1.99321694 |
| 122 | Irregular epiphyses (HP:0010582) | 1.98465926 |
| 123 | Cerebellar dysplasia (HP:0007033) | 1.98358412 |
| 124 | Attenuation of retinal blood vessels (HP:0007843) | 1.96578920 |
| 125 | Hypoglycemic seizures (HP:0002173) | 1.96203748 |
| 126 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.95543293 |
| 127 | J-shaped sella turcica (HP:0002680) | 1.94773313 |
| 128 | Hepatoblastoma (HP:0002884) | 1.93849192 |
| 129 | Cheilitis (HP:0100825) | 1.91456282 |
| 130 | Polyuria (HP:0000103) | 1.90420884 |
| 131 | Myelodysplasia (HP:0002863) | 1.90022790 |
| 132 | Vacuolated lymphocytes (HP:0001922) | 1.89657269 |
| 133 | Macular degeneration (HP:0000608) | 1.89545439 |
| 134 | Selective tooth agenesis (HP:0001592) | 1.89422351 |
| 135 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.88492483 |
| 136 | Duplication of thumb phalanx (HP:0009942) | 1.88438244 |
| 137 | Malnutrition (HP:0004395) | 1.87559591 |
| 138 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.86977777 |
| 139 | Hypoplasia of the fovea (HP:0007750) | 1.86977777 |
| 140 | Orchitis (HP:0100796) | 1.86389460 |
| 141 | Urethral obstruction (HP:0000796) | 1.86183155 |
| 142 | Keratoconjunctivitis sicca (HP:0001097) | 1.86033866 |
| 143 | Gastrointestinal atresia (HP:0002589) | 1.86032668 |
| 144 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.85119297 |
| 145 | Tinnitus (HP:0000360) | 1.84892337 |
| 146 | Neuroendocrine neoplasm (HP:0100634) | 1.84820546 |
| 147 | Biliary tract neoplasm (HP:0100574) | 1.82859896 |
| 148 | Progressive microcephaly (HP:0000253) | 1.81745363 |
| 149 | Thyroid-stimulating hormone excess (HP:0002925) | 1.81382642 |
| 150 | Absent frontal sinuses (HP:0002688) | 1.80421508 |
| 151 | Pheochromocytoma (HP:0002666) | 1.80259026 |
| 152 | Hyperventilation (HP:0002883) | 1.80038466 |
| 153 | Hamartoma of the eye (HP:0010568) | 1.79877568 |
| 154 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.79836565 |
| 155 | Abnormal hair laboratory examination (HP:0003328) | 1.79048504 |
| 156 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.77563125 |
| 157 | Recurrent abscess formation (HP:0002722) | 1.75843104 |
| 158 | Goiter (HP:0000853) | 1.75734184 |
| 159 | Irregular vertebral endplates (HP:0003301) | 1.74971209 |
| 160 | Hyperparathyroidism (HP:0000843) | 1.73868358 |
| 161 | Short tibia (HP:0005736) | 1.73748933 |
| 162 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.72771212 |
| 163 | Progressive sensorineural hearing impairment (HP:0000408) | 1.71596614 |
| 164 | Keratoconjunctivitis (HP:0001096) | 1.71477259 |
| 165 | Increased circulating renin level (HP:0000848) | 1.71361956 |
| 166 | Hypoalbuminemia (HP:0003073) | 1.71216057 |
| 167 | Abnormal albumin level (HP:0012116) | 1.71216057 |
| 168 | Genu varum (HP:0002970) | 1.70884933 |
| 169 | Fibular hypoplasia (HP:0003038) | 1.70678590 |
| 170 | Increased IgM level (HP:0003496) | 1.69644815 |
| 171 | Anal stenosis (HP:0002025) | 1.69138639 |
| 172 | Potter facies (HP:0002009) | 1.68964463 |
| 173 | Facial shape deformation (HP:0011334) | 1.68964463 |
| 174 | Hypomagnesemia (HP:0002917) | 1.68644781 |
| 175 | Type I transferrin isoform profile (HP:0003642) | 1.67333634 |
| 176 | Aplasia cutis congenita (HP:0001057) | 1.67116018 |
| 177 | Hypokinesia (HP:0002375) | 1.66856558 |
| 178 | Abnormality of the vitreous humor (HP:0004327) | 1.65484198 |
| 179 | Confusion (HP:0001289) | 1.65298468 |
| 180 | Abnormal urine output (HP:0012590) | 1.64479407 |
| 181 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.63919929 |
| 182 | Abnormality of alanine metabolism (HP:0010916) | 1.63919929 |
| 183 | Hyperalaninemia (HP:0003348) | 1.63919929 |
| 184 | Broad ribs (HP:0000885) | 1.63163282 |
| 185 | Symptomatic seizures (HP:0011145) | 1.61892693 |
| 186 | Cranial hyperostosis (HP:0004437) | 1.61371278 |
| 187 | Prolonged bleeding time (HP:0003010) | 1.60919311 |
| 188 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.60168823 |
| 189 | Nonprogressive disorder (HP:0003680) | 1.57967609 |
| 190 | Septo-optic dysplasia (HP:0100842) | 1.56334722 |
| 191 | Abnormality of the nasal septum (HP:0000419) | 1.55969300 |
| 192 | Muscle fiber atrophy (HP:0100295) | 1.55620992 |
| 193 | Tracheoesophageal fistula (HP:0002575) | 1.55517411 |
| 194 | Abnormal platelet volume (HP:0011876) | 1.54883152 |
| 195 | Abnormality of abdominal situs (HP:0011620) | 1.54280481 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PLK4 | 8.52303915 |
| 2 | STK24 | 6.32219583 |
| 3 | EPHA2 | 4.19900359 |
| 4 | WNK4 | 4.17302141 |
| 5 | STK39 | 3.97573985 |
| 6 | ACVR1B | 3.48435303 |
| 7 | CASK | 3.24045312 |
| 8 | RPS6KB2 | 3.13770612 |
| 9 | CCNB1 | 2.91162649 |
| 10 | MAP3K2 | 2.87949053 |
| 11 | PINK1 | 2.87751165 |
| 12 | EEF2K | 2.78030543 |
| 13 | MAP3K14 | 2.72660835 |
| 14 | MAP2K3 | 2.25703029 |
| 15 | FRK | 2.25611674 |
| 16 | SIK3 | 2.13763469 |
| 17 | TRIM28 | 1.99454521 |
| 18 | ZAK | 1.86510468 |
| 19 | BCR | 1.63611481 |
| 20 | PIM1 | 1.51119659 |
| 21 | CHUK | 1.47833794 |
| 22 | IRAK3 | 1.47193090 |
| 23 | PIK3CA | 1.45743697 |
| 24 | EIF2AK2 | 1.31750786 |
| 25 | ILK | 1.31116268 |
| 26 | BMPR1B | 1.30564052 |
| 27 | JAK3 | 1.29398675 |
| 28 | TYK2 | 1.29063446 |
| 29 | MST4 | 1.27573410 |
| 30 | ICK | 1.25702382 |
| 31 | AKT3 | 1.22953945 |
| 32 | YES1 | 1.21742688 |
| 33 | FLT3 | 1.19274739 |
| 34 | PRKCQ | 1.18839597 |
| 35 | CAMKK2 | 1.18362437 |
| 36 | INSRR | 1.16753614 |
| 37 | TAOK3 | 1.12669578 |
| 38 | IKBKE | 1.12513673 |
| 39 | STK10 | 1.11554136 |
| 40 | MAP3K4 | 1.11038533 |
| 41 | MARK3 | 1.10819437 |
| 42 | RIPK1 | 1.10758049 |
| 43 | MELK | 1.10601593 |
| 44 | TAOK2 | 1.10467638 |
| 45 | DAPK2 | 1.08404008 |
| 46 | SGK2 | 1.07244333 |
| 47 | TBK1 | 1.07141421 |
| 48 | IKBKB | 1.06250021 |
| 49 | PASK | 1.05167219 |
| 50 | BLK | 1.05005485 |
| 51 | BRSK2 | 1.04197234 |
| 52 | TRPM7 | 1.03391348 |
| 53 | LATS1 | 0.99446451 |
| 54 | CDK7 | 0.99217150 |
| 55 | MUSK | 0.97690854 |
| 56 | TNK2 | 0.95907195 |
| 57 | GRK1 | 0.95828821 |
| 58 | KIT | 0.93648917 |
| 59 | CAMK4 | 0.92586607 |
| 60 | PLK3 | 0.91752901 |
| 61 | MAP3K12 | 0.90927010 |
| 62 | CAMK1G | 0.90704893 |
| 63 | TXK | 0.90607003 |
| 64 | ERN1 | 0.90093836 |
| 65 | WEE1 | 0.87542641 |
| 66 | IRAK4 | 0.87130198 |
| 67 | MAP3K3 | 0.85532108 |
| 68 | STK4 | 0.84923279 |
| 69 | RIPK4 | 0.83462662 |
| 70 | PRKCI | 0.82874559 |
| 71 | MAPK13 | 0.82808193 |
| 72 | ERBB4 | 0.81651696 |
| 73 | EIF2AK3 | 0.80189975 |
| 74 | WNK1 | 0.75552731 |
| 75 | PRKG2 | 0.75506787 |
| 76 | PDK1 | 0.73592074 |
| 77 | TSSK6 | 0.73440043 |
| 78 | MAP2K6 | 0.73319249 |
| 79 | MAPK7 | 0.72137646 |
| 80 | PIM2 | 0.71598231 |
| 81 | SGK3 | 0.71155925 |
| 82 | STK16 | 0.70471367 |
| 83 | CSF1R | 0.69963280 |
| 84 | PRKD3 | 0.69287369 |
| 85 | MAP4K2 | 0.69125469 |
| 86 | AURKB | 0.68003711 |
| 87 | FGFR2 | 0.67864347 |
| 88 | CAMK1D | 0.67833060 |
| 89 | MAPKAPK5 | 0.65194500 |
| 90 | MKNK1 | 0.64583772 |
| 91 | ERBB3 | 0.64581035 |
| 92 | MKNK2 | 0.63301025 |
| 93 | MAPK12 | 0.62931757 |
| 94 | PDPK1 | 0.62355204 |
| 95 | CDK12 | 0.60942960 |
| 96 | CAMK1 | 0.59755341 |
| 97 | PRKAA2 | 0.58607713 |
| 98 | RPS6KA6 | 0.58587832 |
| 99 | TTK | 0.57391213 |
| 100 | PNCK | 0.56546342 |
| 101 | PHKG1 | 0.56250442 |
| 102 | PHKG2 | 0.56250442 |
| 103 | MAP2K7 | 0.55315557 |
| 104 | SGK494 | 0.52117251 |
| 105 | SGK223 | 0.52117251 |
| 106 | CHEK2 | 0.50914750 |
| 107 | DYRK3 | 0.50348773 |
| 108 | MAPKAPK3 | 0.49955320 |
| 109 | PTK2 | 0.49699436 |
| 110 | STK38L | 0.49637005 |
| 111 | CLK1 | 0.49605745 |
| 112 | CDC7 | 0.49283770 |
| 113 | MAP3K13 | 0.48553547 |
| 114 | NLK | 0.47713343 |
| 115 | LMTK2 | 0.46550084 |
| 116 | PKN2 | 0.45935983 |
| 117 | IRAK1 | 0.45293282 |
| 118 | BMPR2 | 0.44750666 |
| 119 | NUAK1 | 0.44614956 |
| 120 | CDK3 | 0.44570586 |
| 121 | PLK1 | 0.44004344 |
| 122 | MAP2K4 | 0.42292263 |
| 123 | HCK | 0.42258858 |
| 124 | BTK | 0.41301899 |
| 125 | ATR | 0.41054232 |
| 126 | BUB1 | 0.40789395 |
| 127 | MST1R | 0.40592025 |
| 128 | TLK1 | 0.40489730 |
| 129 | RPS6KB1 | 0.40275548 |
| 130 | RPS6KC1 | 0.40116888 |
| 131 | RPS6KL1 | 0.40116888 |
| 132 | RET | 0.40011550 |
| 133 | NEK1 | 0.39846631 |
| 134 | OXSR1 | 0.38147027 |
| 135 | MAP2K2 | 0.36927607 |
| 136 | ADRBK1 | 0.35964968 |
| 137 | AKT2 | 0.35563218 |
| 138 | CAMKK1 | 0.34961624 |
| 139 | AKT1 | 0.34292951 |
| 140 | PRKAA1 | 0.34136733 |
| 141 | SRPK1 | 0.33809574 |
| 142 | FER | 0.33660641 |
| 143 | NEK9 | 0.33049611 |
| 144 | PTK2B | 0.32424985 |
| 145 | BRD4 | 0.31473124 |
| 146 | TNIK | 0.31316421 |
| 147 | ABL1 | 0.30983309 |
| 148 | TEC | 0.30915176 |
| 149 | BRAF | 0.30382309 |
| 150 | MAP4K1 | 0.30355126 |
| 151 | CHEK1 | 0.30071506 |
| 152 | SYK | 0.29630317 |
| 153 | ADRBK2 | 0.28406834 |
| 154 | PRKD2 | 0.27821853 |
| 155 | BRSK1 | 0.27395981 |
| 156 | TAOK1 | 0.27108812 |
| 157 | CDK2 | 0.25092092 |
| 158 | MAPKAPK2 | 0.24101234 |
| 159 | CSK | 0.23914252 |
| 160 | EPHB2 | 0.23662566 |
| 161 | MAPK11 | 0.23600683 |
| 162 | PRPF4B | 0.23150762 |
| 163 | SGK1 | 0.22032925 |
| 164 | PRKCD | 0.21891945 |
| 165 | NTRK3 | 0.21765224 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 5.06005362 |
| 2 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.66934837 |
| 3 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.66767716 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.62944005 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.51587760 |
| 6 | Lysine degradation_Homo sapiens_hsa00310 | 2.32839521 |
| 7 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.30744251 |
| 8 | DNA replication_Homo sapiens_hsa03030 | 2.22919519 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 2.20798776 |
| 10 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.19720159 |
| 11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.19400014 |
| 12 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.12711841 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.10253155 |
| 14 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.08716038 |
| 15 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.01835556 |
| 16 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.00642563 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.98660502 |
| 18 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.98230020 |
| 19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.95414678 |
| 20 | Base excision repair_Homo sapiens_hsa03410 | 1.88561892 |
| 21 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.82930825 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.82828733 |
| 23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.79734519 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.78240302 |
| 25 | Allograft rejection_Homo sapiens_hsa05330 | 1.77722851 |
| 26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.74680517 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.71977081 |
| 28 | Measles_Homo sapiens_hsa05162 | 1.69257444 |
| 29 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.66247143 |
| 30 | Homologous recombination_Homo sapiens_hsa03440 | 1.63918462 |
| 31 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.59698229 |
| 32 | Phototransduction_Homo sapiens_hsa04744 | 1.59594244 |
| 33 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.57517797 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.56928233 |
| 35 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.56868448 |
| 36 | Leishmaniasis_Homo sapiens_hsa05140 | 1.54584548 |
| 37 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.46516714 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.46500976 |
| 39 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.46400800 |
| 40 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.45597778 |
| 41 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.45538149 |
| 42 | Proteasome_Homo sapiens_hsa03050 | 1.45086935 |
| 43 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.43367087 |
| 44 | Cell cycle_Homo sapiens_hsa04110 | 1.41769178 |
| 45 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.40427107 |
| 46 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.40140680 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.39654859 |
| 48 | Insulin secretion_Homo sapiens_hsa04911 | 1.38227828 |
| 49 | * Hippo signaling pathway_Homo sapiens_hsa04390 | 1.36831090 |
| 50 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.36351968 |
| 51 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.34742559 |
| 52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.34705705 |
| 53 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.34695710 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 1.32225484 |
| 55 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.30501074 |
| 56 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.30395907 |
| 57 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.28744822 |
| 58 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.28482722 |
| 59 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.28104556 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.27071660 |
| 61 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.26645560 |
| 62 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.25591042 |
| 63 | Pertussis_Homo sapiens_hsa05133 | 1.22400476 |
| 64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.21716999 |
| 65 | Hepatitis C_Homo sapiens_hsa05160 | 1.21173523 |
| 66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.19736354 |
| 67 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.18995131 |
| 68 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.14639537 |
| 69 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.13109152 |
| 70 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.11575882 |
| 71 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.09786313 |
| 72 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.09419558 |
| 73 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.09118896 |
| 74 | Apoptosis_Homo sapiens_hsa04210 | 1.07145285 |
| 75 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.07100895 |
| 76 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.06771230 |
| 77 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.06137117 |
| 78 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.04488475 |
| 79 | Sulfur relay system_Homo sapiens_hsa04122 | 1.03958671 |
| 80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.03174888 |
| 81 | Shigellosis_Homo sapiens_hsa05131 | 1.01731789 |
| 82 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.01126029 |
| 83 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.01075222 |
| 84 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.99342252 |
| 85 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.98994629 |
| 86 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.98885397 |
| 87 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.98474425 |
| 88 | Lysosome_Homo sapiens_hsa04142 | 0.97693229 |
| 89 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.97486027 |
| 90 | Adherens junction_Homo sapiens_hsa04520 | 0.96517724 |
| 91 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.96400941 |
| 92 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.96399545 |
| 93 | RNA transport_Homo sapiens_hsa03013 | 0.91511837 |
| 94 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.91480208 |
| 95 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.90516324 |
| 96 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.89742376 |
| 97 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.89647038 |
| 98 | Salmonella infection_Homo sapiens_hsa05132 | 0.88794047 |
| 99 | Taste transduction_Homo sapiens_hsa04742 | 0.88676481 |
| 100 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.87792785 |
| 101 | Endometrial cancer_Homo sapiens_hsa05213 | 0.87657314 |
| 102 | Bile secretion_Homo sapiens_hsa04976 | 0.87220152 |
| 103 | Other glycan degradation_Homo sapiens_hsa00511 | 0.86184433 |
| 104 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.84722672 |
| 105 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.84008068 |
| 106 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.83156189 |
| 107 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.81287748 |
| 108 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.81105503 |
| 109 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.80607796 |
| 110 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.79415449 |
| 111 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.78200312 |
| 112 | Hepatitis B_Homo sapiens_hsa05161 | 0.78099421 |
| 113 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.77789250 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.76440813 |
| 115 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.76105441 |
| 116 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.76066826 |
| 117 | Tuberculosis_Homo sapiens_hsa05152 | 0.74744512 |
| 118 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74459658 |
| 119 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74208988 |
| 120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.73129776 |
| 121 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.72915381 |
| 122 | Retinol metabolism_Homo sapiens_hsa00830 | 0.70701422 |
| 123 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.70320345 |
| 124 | Purine metabolism_Homo sapiens_hsa00230 | 0.69830056 |
| 125 | Nicotine addiction_Homo sapiens_hsa05033 | 0.68515977 |
| 126 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.68433249 |
| 127 | Spliceosome_Homo sapiens_hsa03040 | 0.68387012 |
| 128 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67614239 |
| 129 | RNA degradation_Homo sapiens_hsa03018 | 0.67534809 |
| 130 | Mineral absorption_Homo sapiens_hsa04978 | 0.66967882 |
| 131 | Peroxisome_Homo sapiens_hsa04146 | 0.66264042 |
| 132 | Viral myocarditis_Homo sapiens_hsa05416 | 0.65078418 |
| 133 | Tight junction_Homo sapiens_hsa04530 | 0.64507829 |
| 134 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.64227315 |
| 135 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63425450 |
| 136 | Pathways in cancer_Homo sapiens_hsa05200 | 0.62830663 |
| 137 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62561796 |
| 138 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.60943339 |
| 139 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.60758800 |
| 140 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60370024 |
| 141 | HTLV-I infection_Homo sapiens_hsa05166 | 0.60056623 |
| 142 | Phagosome_Homo sapiens_hsa04145 | 0.59092627 |
| 143 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.58301407 |
| 144 | Insulin resistance_Homo sapiens_hsa04931 | 0.57582427 |
| 145 | Histidine metabolism_Homo sapiens_hsa00340 | 0.56816728 |
| 146 | Prostate cancer_Homo sapiens_hsa05215 | 0.55528697 |
| 147 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.55316073 |
| 148 | Salivary secretion_Homo sapiens_hsa04970 | 0.55142624 |
| 149 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.54853979 |
| 150 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53021013 |
| 151 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.51905858 |
| 152 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50498648 |
| 153 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.50082920 |
| 154 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.49462474 |
| 155 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48530969 |
| 156 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.48390675 |
| 157 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.48086861 |
| 158 | Asthma_Homo sapiens_hsa05310 | 0.47440851 |
| 159 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47334154 |
| 160 | Long-term depression_Homo sapiens_hsa04730 | 0.46969706 |
| 161 | RNA polymerase_Homo sapiens_hsa03020 | 0.46845954 |
| 162 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46813121 |
| 163 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.46547141 |
| 164 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.46272996 |
| 165 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46013270 |
| 166 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.45916289 |
| 167 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45417034 |
| 168 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.42895852 |
| 169 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.42388080 |
| 170 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42098656 |
| 171 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.40020981 |
| 172 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.39468870 |
| 173 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39198010 |
| 174 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36017176 |
| 175 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.34852758 |
| 176 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.31248310 |
| 177 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.28848888 |
| 178 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.26706605 |
| 179 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.25238814 |

